DE60308164D1 - Prozess zur herstellung einer sterilen suspension von corticoid-partikeln zur verabreichung durch inhalation - Google Patents

Prozess zur herstellung einer sterilen suspension von corticoid-partikeln zur verabreichung durch inhalation

Info

Publication number
DE60308164D1
DE60308164D1 DE60308164T DE60308164T DE60308164D1 DE 60308164 D1 DE60308164 D1 DE 60308164D1 DE 60308164 T DE60308164 T DE 60308164T DE 60308164 T DE60308164 T DE 60308164T DE 60308164 D1 DE60308164 D1 DE 60308164D1
Authority
DE
Germany
Prior art keywords
corticoid
inhalation
administration
particles
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308164T
Other languages
English (en)
Other versions
DE60308164T2 (de
Inventor
Barbara Sambuco
Daniele Pirrotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE60308164D1 publication Critical patent/DE60308164D1/de
Application granted granted Critical
Publication of DE60308164T2 publication Critical patent/DE60308164T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE60308164T 2002-04-17 2003-04-15 Verfahren zur Herstellung einer sterilen Suspension von Corticosteroiden zur Verabreichung durch Inhalation Expired - Lifetime DE60308164T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20020808 2002-04-17
IT2002MI000808A ITMI20020808A1 (it) 2002-04-17 2002-04-17 Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
PCT/EP2003/003916 WO2003086347A1 (en) 2002-04-17 2003-04-15 Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation

Publications (2)

Publication Number Publication Date
DE60308164D1 true DE60308164D1 (de) 2006-10-19
DE60308164T2 DE60308164T2 (de) 2007-08-09

Family

ID=11449718

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308164T Expired - Lifetime DE60308164T2 (de) 2002-04-17 2003-04-15 Verfahren zur Herstellung einer sterilen Suspension von Corticosteroiden zur Verabreichung durch Inhalation

Country Status (25)

Country Link
US (1) US7541021B2 (de)
EP (1) EP1494647B1 (de)
CN (1) CN1292733C (de)
AR (1) AR039317A1 (de)
AT (1) ATE338539T1 (de)
AU (1) AU2003227627A1 (de)
BR (1) BRPI0304821B8 (de)
CA (1) CA2481520C (de)
CY (1) CY1105800T1 (de)
DE (1) DE60308164T2 (de)
DK (1) DK1494647T3 (de)
EA (1) EA007629B1 (de)
ES (1) ES2272987T3 (de)
HK (1) HK1079986B (de)
HR (1) HRP20040964A2 (de)
IT (1) ITMI20020808A1 (de)
MA (1) MA27194A1 (de)
MX (1) MXPA04010117A (de)
PE (1) PE20030948A1 (de)
PL (1) PL207863B1 (de)
PT (1) PT1494647E (de)
SI (1) SI1494647T1 (de)
UA (1) UA79453C2 (de)
WO (1) WO2003086347A1 (de)
ZA (1) ZA200408319B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
MXPA06004489A (es) * 2003-10-23 2006-06-20 Otsuka Pharma Co Ltd Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada.
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1683514B1 (de) 2005-01-20 2012-05-23 Eratech S.r.l. Verfahren zur Herstellung konzentrierter Suspensionen und Kit davon
EP2279727A3 (de) * 2005-09-15 2011-10-05 Elan Pharma International Limited Nanoteilchenförmige Aripiprazolformulierungen
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
JP2009526858A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー コルチコステロイド溶液を製造する方法
HUE030605T2 (hu) * 2007-06-22 2017-05-29 Dompe Farm Spa Inhalációs alkalmazásra szolgáló pezsgõtabletták
TWI410255B (zh) * 2007-07-31 2013-10-01 Otsuka Pharma Co Ltd 阿立哌唑（Ａｒｉｐｉｐｒａｚｏｌｅ）懸浮液及冷凍乾燥調配物之製法
CN102475708A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 丙酸氟替卡松和含辅料的水构成的治疗皮肤病的分离式水混悬剂药物
CN102657659A (zh) * 2010-11-23 2012-09-12 天津金耀集团有限公司 皮肤用含有辅料的丙酸氟替卡松与含有辅料的水的透皮吸收药物
PT2704724T (pt) 2011-05-03 2017-02-02 Chiesi Farm Spa Formulação de suspensão de dipropionato de beclometasona melhorada para administração por inalação
CN103505412A (zh) * 2012-06-26 2014-01-15 上海臣邦医药科技有限公司 一种吸入用丙酸氟替卡松混悬液的制备方法
WO2022098321A1 (en) * 2020-11-09 2022-05-12 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilised suspensions for the administration by inhalation
WO2022231531A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2023022672A2 (en) * 2021-08-18 2023-02-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of homogeneous suspensions for the inhalation by nebulization

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Also Published As

Publication number Publication date
BR0304821A (pt) 2004-06-15
CA2481520C (en) 2011-02-22
BRPI0304821B1 (pt) 2018-11-06
PL373331A1 (en) 2005-08-22
ZA200408319B (en) 2006-03-29
EA007629B1 (ru) 2006-12-29
ITMI20020808A1 (it) 2003-10-17
MXPA04010117A (es) 2004-12-13
PE20030948A1 (es) 2004-01-19
ITMI20020808A0 (it) 2002-04-17
US7541021B2 (en) 2009-06-02
CN1652748A (zh) 2005-08-10
CY1105800T1 (el) 2011-02-02
PT1494647E (pt) 2007-01-31
SI1494647T1 (sl) 2007-02-28
EP1494647A1 (de) 2005-01-12
EA200401209A1 (ru) 2005-10-27
DK1494647T3 (da) 2007-01-15
AR039317A1 (es) 2005-02-16
HRP20040964A2 (en) 2005-02-28
EP1494647B1 (de) 2006-09-06
CA2481520A1 (en) 2003-10-23
MA27194A1 (fr) 2005-01-03
UA79453C2 (en) 2007-06-25
HK1079986A1 (en) 2006-04-21
ES2272987T3 (es) 2007-05-01
PL207863B1 (pl) 2011-02-28
BRPI0304821B8 (pt) 2021-05-25
DE60308164T2 (de) 2007-08-09
AU2003227627A1 (en) 2003-10-27
US20050175546A1 (en) 2005-08-11
CN1292733C (zh) 2007-01-03
HK1079986B (zh) 2007-05-11
ATE338539T1 (de) 2006-09-15
WO2003086347A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
DE60308164D1 (de) Prozess zur herstellung einer sterilen suspension von corticoid-partikeln zur verabreichung durch inhalation
DE60308596D1 (de) Verfahren zur Herstellung von anorganisichen Nanoröhren
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE50303749D1 (de) Verfahren zur herstellung von phthalocyaninpigmentzubereitungen
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE60228118D1 (de) Verfahren zur herstellung von o-desmethylvenlafaxin
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE60208738D1 (de) Verfahren zur Herstellung von Chlorfluorpolyoxyalkylenolen
DE60110200D1 (de) Verfahren zur Herstellung von Prepregs
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE60323793D1 (de) Verfahren zur Herstellung von Fluorhalogenethern
DE60105209D1 (de) Verfahren zur Herstellung von niedrig substituierter Hydroxypropylcellulose-Partikeln
DE50210487D1 (de) Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE50211253D1 (de) Verfahren zur Herstellung von Makrokapseln
AU2003294100A1 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
DE60213217D1 (de) Verfahren zur Herstellung von lithographischen Masken
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE60210009D1 (de) Verfahren zur Herstellung von Zyklopropankarboxylaten
DE602004012183D1 (de) Verfahren zur Herstellung von reinem Titanbaustoff
DE60303872D1 (de) Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin
DE50207073D1 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition